| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/16/1997 | CA2224346A1 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a |
| 01/16/1997 | CA2220554A1 Use of il-11 to treat inflammation |
| 01/15/1997 | EP0753512A1 N,N,-diethyl-8,8dipropyl-2-azaspiro(4,5)decane-2-propanamine dimaleate salt |
| 01/15/1997 | EP0753300A1 Use of antioxidative steroids for the manufacture of pharmaceutical preparations for substition therapy in man |
| 01/15/1997 | EP0753297A1 Lotion |
| 01/15/1997 | EP0753296A2 Oral formulations of S(+)-ibuprofen |
| 01/15/1997 | EP0753065A1 Antibodies against e-selectin |
| 01/15/1997 | EP0752994A1 IMIDAZO[1,2-a]PYRAZIN-4-ONE DERIVATIVES, THEIR PREPARATION AND DRUGS CONTAINING THEM |
| 01/15/1997 | EP0752993A1 1,2,4-TRIAZOLO[4,3-a]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 01/15/1997 | EP0752992A1 Imidazo(1,2-a)indeno(1,2-e)pyrazine-4-one derivatives and pharmaceutical compositions containing same |
| 01/15/1997 | EP0752991A1 INDENO[1,2-e]PYRAZINE-4-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 01/15/1997 | EP0752990A1 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis |
| 01/15/1997 | EP0752988A1 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 01/15/1997 | EP0752987A1 Pyrimidinyl derivatives as interleukin inhibitors |
| 01/15/1997 | EP0752886A1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| 01/15/1997 | EP0752884A1 Method of treating auto-immune diseases using type one interferons |
| 01/15/1997 | EP0752880A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon |
| 01/15/1997 | EP0752879A1 TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES |
| 01/15/1997 | EP0752875A1 Glioblastoma-derived angiogenesis inhibiting factor |
| 01/15/1997 | EP0752864A1 Use of growth factor protecting polymers for treating inflammation |
| 01/15/1997 | EP0752849A1 Heme-bearing microparticles for targeted delivery of drugs |
| 01/15/1997 | EP0642332B1 Ophthalmic compositions containing a cyclosporin |
| 01/15/1997 | EP0595995B1 Arylamidoalkyl- and arylaminoalkyl-n-hydroxyurea compounds and -n-hydroxyformamide derivatives having lipoxygenase inhibitory activity |
| 01/15/1997 | EP0584091B1 Benzopyranones, methods of manufacture and use thereof |
| 01/15/1997 | CN1140456A Superagonists and antagonists of H IL-6, and 3-D modelling method for their selection |
| 01/15/1997 | CN1140455A Diastereomeric pure trifluoromethyl ketone peptide derivs. as inhibitors of human leukocyte elastase |
| 01/15/1997 | CN1140448A New compounds with analgesic and local anaesthetic effect |
| 01/15/1997 | CN1140413A Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| 01/15/1997 | CN1140178A Use of new steroid compound for preparing medicaments |
| 01/15/1997 | CN1140086A Chinese patent drug "Bizhengning" for treatment of arthralgia-syndrome |
| 01/15/1997 | CN1140059A Process for preparing pharmaceutical composition contg. new steroid compounds |
| 01/14/1997 | US5594154 5-amino-2-bromomethyl-2,4,6,7-tetramethyl-2,3-dihydrobenzo(b) furans |
| 01/14/1997 | US5594022 Carbamates |
| 01/14/1997 | US5594008 Pyrrolidine derivatives inhibitors of leukotriene biosynthesis |
| 01/14/1997 | US5593994 Prostaglandin synthase inhibitors |
| 01/14/1997 | US5593992 Cytokine inhibitors |
| 01/14/1997 | US5593991 Imidazole compounds, use and process of making |
| 01/14/1997 | US5593990 Methods and compositions for inhibition of angiogenesis |
| 01/14/1997 | US5593980 Antiarthritic agents for administering |
| 01/14/1997 | US5593976 New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds |
| 01/14/1997 | US5593960 Producing cyclomarin a from fermentation of streptomyces |
| 01/14/1997 | US5593884 Oncoprotein protein kinase |
| 01/14/1997 | US5593882 Selectin variants |
| 01/14/1997 | US5593658 Medical compositions |
| 01/14/1997 | CA2045680C High ibuprofen content granulations |
| 01/09/1997 | WO1997000952A2 A human edg-2 receptor homolog |
| 01/09/1997 | WO1997000864A1 Aromatic compounds and pharmaceutical compositions containing them |
| 01/09/1997 | WO1997000860A1 Cb2 receptor agonist compounds |
| 01/09/1997 | WO1997000695A1 Haemopoietic growth factor antagonists and uses therefor |
| 01/09/1997 | WO1997000675A1 Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders |
| 01/09/1997 | CA2225517A1 Haemopoietic growth factor antagonists and uses therefor |
| 01/09/1997 | CA2225379A1 Cb2 receptor agonist compounds |
| 01/09/1997 | CA2225277A1 Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders |
| 01/09/1997 | CA2224799A1 A human edg-2 receptor homolog |
| 01/09/1997 | CA2220529A1 Aromatic compounds and pharmaceutical compositions containing them |
| 01/08/1997 | EP0752246A2 Kappa opiate agonists for inflammatory gut diseases |
| 01/08/1997 | EP0751992A1 Vascular endothelial growth factor 2 |
| 01/08/1997 | EP0751957A1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 01/08/1997 | EP0751954A1 Anti-inflammatory composition and method with des-tyr dynorphin and analogues |
| 01/08/1997 | EP0751948A1 Novel phosphoramidate and phophorothioamidate oligomeric compounds |
| 01/08/1997 | EP0751932A1 Vitamin-d amide derivatives |
| 01/08/1997 | EP0668863B1 Quinuclidine derivative as substance p antagonist |
| 01/08/1997 | EP0469075B1 Use of lipoxin a 4? and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 01/08/1997 | EP0341273B1 Biological materials, processes for producing biological materials and for using such materials in therapy |
| 01/08/1997 | CN1139931A Cyclic neurokinin a antagonists |
| 01/08/1997 | CN1139927A Substituted morpholine derivatives and their use as therapeutic agents |
| 01/08/1997 | CN1139880A Diphenyl-2-propenoates and homologs thereof useful for threating diseases associated with leukotriene B4 |
| 01/07/1997 | US5591835 Substituted lactose derivatives |
| 01/07/1997 | US5591827 Interleukin-6 receptor antagonists |
| 01/07/1997 | US5591777 Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions |
| 01/07/1997 | US5591776 Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV |
| 01/07/1997 | US5591772 Dietary supplements |
| 01/07/1997 | US5591761 Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 01/07/1997 | US5591452 Controlled release formulation |
| 01/07/1997 | CA2043715C Imidazonaphthyridine derivatives |
| 01/07/1997 | CA2033497C 3-aminopiperidine derivatives and related nitrogen containing heterocycles |
| 01/03/1997 | WO1997000242A1 Novel vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
| 01/03/1997 | WO1997000079A1 P-selectin ligands and related molecules and methods |
| 01/03/1997 | WO1997000063A2 Urocortin peptides |
| 01/03/1997 | CA2224625A1 P-selectin ligands and related molecules and methods |
| 01/03/1997 | CA2224440A1 New vitamin d derivatives with substituents at c-25, process for their production, intermediate products and use for the production of pharmaceutical agents |
| 01/03/1997 | CA2223792A1 Urocortin peptides |
| 01/02/1997 | EP0751147A1 Toxoplasma gondii antigen, its production and use |
| 01/02/1997 | EP0751137A1 Oxaindene derivatives and a process for preparing them as well as medicaments containing them and the use of them |
| 01/02/1997 | EP0750666A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS |
| 01/02/1997 | EP0750640A1 Delipidated purified polysaccharide compound d25 preparation, and injectable composition comprising same |
| 01/02/1997 | EP0750607A1 2-(aminoalkoxy)phenylalkylamines with antiinflammatory activity |
| 01/02/1997 | EP0750511A1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor |
| 01/02/1997 | EP0750507A1 PROTEASOME REGULATION OF NF-$g(k)B ACTIVITY |
| 01/02/1997 | EP0680328B1 Topical ketoconazole compositions |
| 01/02/1997 | EP0564461B1 The use of antibodies to tnf or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor |
| 01/01/1997 | CN1139435A New ginkgolide derivatives and process for preparing them |
| 01/01/1997 | CN1139434A Diazabicyclic neurokinin antagonists |
| 01/01/1997 | CN1139430A Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 01/01/1997 | CN1139383A Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 01/01/1997 | CN1139116A Radioactive chitosan complex, its macroaggrgate and kit for preparing radioactive chitosan complex, process for preparation thereof, and use thereof for radiation therapy |
| 01/01/1997 | CN1139110A Inhibitng photodecomposition of 3-substituted-2-oxindoles |
| 12/31/1996 | US5589514 Arylcycloalkyl derivatives, their production and their use |
| 12/31/1996 | US5589471 Vitamin D analogues containing a hydroxy or alkylated hydroxy group in the 20-position |
| 12/31/1996 | US5589465 Glycolipid derivatives acting as ligands for selectins |